Monday, March 25, 2024
HomeEditor PicksNew Blood Test For Detecting Alzheimer's Disease

New Blood Test For Detecting Alzheimer’s Disease

Blood Test Can Predict Presence Of Beta

New blood test for Alzheimer’s could detect disease decades in advance

Scientists have demonstrated that a new blood test can accurately predict the presence of beta-amyloid plaques in the brain, according to a new study funded in part by NIA. Published in Neurology, the study analyzed the ability of a blood test to predict the presence of Alzheimers disease-associated protein beta-amyloid in the brain. The new blood test, which performs comparably to existing brain scan- or spinal tap-based tests, could lower costs and expand the availability of diagnostic studies for Alzheimers disease.

Alzheimers is characterized by the buildup of a protein called beta-amyloid, which forms sticky plaques on the brain and can cause brain cells to die. Testing for the presence of these amyloid plaques on the brain is an important part of Alzheimers diagnosis and research. For people experiencing memory problems, checking for amyloid in the brain helps health care providers determine whether Alzheimers is the potential cause. It also can help doctors determine which patients will respond to drugs that target amyloid. For people without any signs of dementia, the presence of amyloid plaques on the brain may help researchers enroll participants in clinical trials for treatments to prevent or delay the onset of cognitive symptoms.

This research was supported in part by NIA grants RF1AG061900, R56AG061900, K23AG053426, 5U19AG024904-14, and 3U19AG024904-15S1.

How Is Alzheimers Disease Usually Detected

Paulson: Doctors usually make a clinical diagnosis of Alzheimers disease based on the history of the illness, cognitive assessment, a neurologic examination and often standard brain imaging. It is an imperfect science and we are not always right in concluding that the diagnosis is Alzheimers rather than some other form of dementia.

Testing the cerebrospinal fluid for biomarkers of Alzheimers can lead to a more precise diagnosis, but many patients are not eager to undergo the spinal tap needed to get this answer, and sometimes insurance companies wont pay for the test.

New imaging methods allow is to visualize the key Alzheimers proteins in the brain, namely beta-amyloid and tau, but these imaging procedures are expensive and not yet covered by insurance.

Detecting Alzheimers Gets Easier With A Simple Blood Test

New assays could reduce the need for costlier, more invasive brain scans and spinal fluid measures

When a patient complains of forgetfulness, a neurologist might not know immediately whether it results from normal aging, reduced blood flow to the brainor, more ominously, Alzheimers disease. For much of the past century, a definitive Alzheimers diagnosis could only be made during an autopsy. Brain imaging and spinal fluid tests now make it possible to spot the disease in patients even before the initial symptoms appear. But these invasive tests are expensive and generally limited to research settings that are not part of routine care for the millions of people suffering from the most common neurodegenerative disorder.

An era in which an Alzheimers diagnosis can begin in a doctors office is now arriving. Advances in technologies to detect early signs of disease from a blood sample are helping doctors to identify the memory-robbing disorder more accurately and to screen participants more quickly for trials of potential treatments for the more than five million people in the U.S. afflicted with Alzheimers.

The development of a blood-based test for Alzheimers disease is just phenomenal, says Michelle Mielke, a neuroscientist and epidemiologist at the Mayo Clinic. The field has been thinking about this for a very long time. Its really been in the last couple of years that the possibility has come to fruition.

Also Check: How To Become A Dementia Specialist Nurse

Is It Alzheimers This Revolutionary Blood Test Gives Doctors An Easy Way To Tell

A simple but revolutionary blood test is aiding in the early detection of Alzheimer’s disease.Canva stock photo

No one wants a diagnosis of dementia.

But if Alzheimers is what Harold had, the 74-year-old attorney from Passaic County wanted to know. And a simple but revolutionary blood test helped him find out.

If you purchase a product or register for an account through one of the links on our site, we may receive compensation.

Scientists Develop Simple Blood Test For Early Detection Of Alzheimer’s Disease

Alzheimer
Date:
Hong Kong University of Science and Technology
Summary:
An international research team has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer’s disease with an accuracy level of over 96%.

An international research team led by HKUST has developed a simple but robust blood test from Chinese patient data for early detection and screening of Alzheimer’s disease for the first time, with an accuracy level of over 96%.

Currently, doctors mainly rely on cognitive tests to diagnose a person with AD. Besides clinical assessment, brain imaging and lumbar puncture are the two most commonly used medical procedures to detect changes in the brain caused by AD. However, these methods are expensive, invasive, and frequently unavailable in many countries.

“With the advancement of ultrasensitive blood-based protein detection technology, we have developed a simple, noninvasive, and accurate diagnostic solution for AD, which will greatly facilitate population-scale screening and staging of the disease,” said Prof. Nancy Ip, Morningside Professor of Life Science and the Director of the State Key Laboratory of Molecular Neuroscience at HKUST.

Story Source:

Read Also: Cognitive Test Questions For Dementia

This Is How The New Blood Test That Can Detect Parkinson’s And Dementia Works

2022-11-09T07:38:23.430Z

A new test that costs several hundred shekels and is conducted at Sheba Tel Hashomer can check for damage to the nervous system, and thus it can warn of the existence of degenerative diseases. How It Works?

Dr. Tamara Shiner explains what Parkinson’s disease is and how to live alongside it

Is there a blood test that can detect degenerative diseases of the brain such as dementia or Parkinson’s?

In a recent experiment conducted at the Sheba Tel Hashomer Hospital on 200 people, it was found that a test called NFL that examines the presence of neurofilaments – proteins that form the internal structure of the nerves – may signal whether there is a chance of degenerative brain diseases in the subject.

The test, which costs NIS 800, is conducted at the Sheba Hospital, was developed by the American company Quantrix, and is performed using a unique device.

“When there is nerve damage such as trauma, caused by a head injury, inflammation and even a disc that damages the spinal cord, the breakdown of the nerve structure occurs, which raises the neurofilaments in the blood,” explains Dr. Amir Dori, a neurology specialist and head of the neuromuscular clinic at Sheba. “The great innovation that happened in recent years The fact that there is technology that makes it possible to test very low levels of proteins in the blood, and in this case very small pieces of nerves in the blood, which we test.

Can detect Parkinson’s before time.

A man with Parkinson’s disease

Summary Of Test And Benefits

Knowing that your symptoms are due to Alzheimers can help inform your healthcare provider to prescribe specific Alzheimers treatments in order to aid in the management of the disease. If your symptoms are unlikely due to Alzheimers , your healthcare provider can search for other causes, some of which can be treated with different interventions.

Earlier detection provides the opportunity for earlier care options, including clinical trials. Many clinical trials for Alzheimers disease are looking for participants who show initial signs of cognitive impairment. You also may be eligible to enroll in clinical trials as a result of the PrecivityAD test results.

Researchers at CN Diagnostics have found the PrecivityAD test results to be an accurate indicator of Alzheimers disease pathology among people with memory and thinking issues. The PrecivityAD test is easy to administer, does not involve any radiation, and is non-invasive. These features make it more accessible than other diagnostic methods doctors use to evaluate issues with memory and thinking.

You May Like: Can Namenda Make Dementia Worse

Wondering Where To Get An Alzheimers Blood Test Currently Three Brands Are Commercially Available In The Us Heres A Quick Look At Where To Get Them And How Much They Cost

The gold-standard methods for diagnosing Alzheimers disease are lumbar punctures and PET brain scans. But these methods can be uncomfortable not to mention expensive and hard to access. Thus, there is a great deal of research being done into easier, more accessible diagnostics including blood tests.

Blood tests and computerized cognitive tests provide a proxy of amyloid levels in the brain, are quicker to administer, and may allow for more people to be screened for the disease. As of September 2022, there are three commercially available Alzheimers blood tests for U.S. citizens, though only one of them may be covered by private insurance. At the moment, none of them are covered by the Centers for Medicare & Medicaid Services.

No Cure For Alzheimers

New Mexico researchers developing blood test to detect Alzheimers

People who suffer from Alzheimers often experience a decline in memory, thinking, and reasoning skills.

There is no cure for Alzheimers but drugs are available that temper its impact and slow some of the debilitating symptoms, such as the decline in memory.

The Alzheimers Association says there are 10 symptoms of the disease, including disruptive memory loss, challenges in planning or solving problems, difficulty in completing familiar tasks, confusion with time and place, as well as misplacing things.

An estimated 5.7 million Americans of all ages are living with Alzheimers disease in 2019, according to the Alzheimers Association. Worldwide, the number of people living with Alzheimers and other forms of dementia is estimated at 50 million.

The Association predicts that by 2050, the number of people living with the disease in the United States is estimated to rise to almost 14 million, and the costs of Alzheimers to the nation will grow from the current $277 billion to as much as $1.1 trillion.

Every 65 seconds someone in the United States develops the disease, the Association states.

Also Check: When Do You Get Dementia

New Blood Test For Detecting Alzheimer’s Disease

by Lund University

Researchers from Lund University, together with the Roche pharmaceutical company, have developed a method to create a new blood marker capable of detecting whether or not a person has Alzheimer’s disease. If the method is approved for clinical use, the researchers hope eventually to see it used as a diagnostic tool in primary healthcare. This autumn, they will start a trial in primary healthcare to test the technique.

Currently, a major support in the diagnostics of Alzheimer’s disease is the identification of abnormal accumulation of the substance beta-amyloid, which can be detected either in a spinal fluid sample or through brain imaging using a PET scanner.

“These are expensive methods that are only available in specialist healthcare. In research, we have therefore long been searching for simpler diagnostic tools,” says Sebastian Palmqvist, associate professor at the unit for clinical memory research at Lund University, physician at Skåne University Hospital and lead author of the study.

The results are published in JAMA Neurology and based on studies of blood analyses collected from 842 people in Sweden and 237 people in Germany. The participants in the study are Alzheimer’s patients with dementia, healthy elderly people and people with mild cognitive impairment.

More information:JAMA NeurolJournal information:

Much More Than Tremors: This Is What You Must Know About Parkinson’s

To the full article

“The test is a kind of screening test. It is recommended to be performed if there is a family history or active damage – headaches for an unknown reason, sensory disturbances from an unknown place,” explains Dr. Dori. He emphasizes that “the test can provide evidence that there is active damage and after It should start searching.

It does not replace other tests.

After the active damage is over, the amount of neurofilaments returns to normal.

It doesn’t mean anything about the past or the future, unless there is a high level and it doesn’t decrease, then a comprehensive inquiry is made, checking, among other things, whether there are symptoms of Parkinson’s or ALS.

Also Check: What Does Alzheimer’s Disease Affect

Blood Tests For Dementia Alzheimers A New Way To Diagnosis These Diseases

Scientists have been working for decades on developing new methods that would accurately detect signs and symptoms of Alzheimers disease. Prior to the early 2000s, the only way to know for sure whether a person had Alzheimers was to conduct an autopsy after the individual died, according to the National Institute of Aging.

Now, researchers believe a new generation of blood tests can more accurately diagnose Alzheimers, a brain disease that slowly worsens over time and causes memory loss and other cognitive problems.

More than 6 million people in the United States are living with Alzheimers, which is the most common cause of dementia, according to the Alzheimers Association. Alzheimers has no cure, but treatment can slow the progression of the disease.

Stephen Salloway, a professor of neurology and psychiatry at Brown University who directs a memory and aging program at Butler Hospital in Providence, Rhode Island, says the new blood tests represent a very early start to a new era of diagnosis for Alzheimers disease.

Scientists say that blood tests are not as expensive or invasive as brain imaging, spinal fluid tests, and other methods used to determine signs and symptoms of Alzheimers. A blood test might also be more practical for people who do not have access to memory clinics or specialists who can diagnose Alzheimers disease.

In addition to a PET scan or spinal tap, doctors diagnose Alzheimers disease by using other methods that include:

Simple Blood Test May Be Able To Diagnose Alzheimers Disease

health studies

A simple blood test may soon be able to diagnose patients with two common forms of dementia Alzheimers disease and frontotemporal dementia and tell the two apart.

Researchers at UC San Francisco analyzed the blood test in more than 300 patients and say they hope to see such a test available in doctors offices within five years.

This test could eventually be deployed in a primary care setting for people with memory concerns to identify who should be referred to specialized centers to participate in clinical trials or to be treated with new Alzheimers therapies, once they are approved, said Adam Boxer, MD, PhD, neurologist at the UCSF Memory and Aging Center and senior author of the study published in Nature Medicine. Boxer also is affiliated with the UCSF Weill Institute for Neurosciences.

No blood test currently exists for either condition. Alzheimers diagnoses can only be confirmed by a PET scan of the brain, which can be costly, or an invasive lumbar puncture to test cerebrospinal fluid.

If approved, the new blood test could ease screening and help increase the number of patients eligible for clinical trials, which are essential to the search for drugs to stop or slow dementia. Patients who know whether they have Alzheimers or FTD are also better able to manage their symptoms, which may differ between the two conditions.

Adam Boxer, MD, PhD

Also Check: What Causes Aggression In Dementia Patients

Alzheimer’s Disease: A Guide To Diagnosis Treatment And Caregiving

Have you noticed memory problems piling up in ways that affect daily life in yourself or someone you love? Do you find yourself struggling to follow a conversation or find the right word, becoming confused in new places, or botching tasks that once came easily? More than 5 million Americans have Alzheimers disease, and estimates suggest it will affect 13.8 million by 2050. Already, it is the sixth leading cause of death in the United States. This Special Health Report, Alzheimer’s Disease: A guide to coping, treatment, and caregiving, includes in-depth information on diagnosing Alzheimers and treating its symptoms.

Get the latest in health news delivered to your inbox!

Thanks for visiting. Don’t miss your FREE gift.

The Best Diets for Cognitive Fitness, is yours absolutely FREE when you sign up to receive Health Alerts from Harvard Medical School

Sign up to get tips for living a healthy lifestyle, with ways to fight inflammation and improve cognitive health, plus the latest advances in preventative medicine, diet and exercise, pain relief, blood pressure and cholesterol management, and more.

Health Alerts from Harvard Medical School

Get helpful tips and guidance for everything from fighting inflammation to finding the best diets for weight loss…from exercises to build a stronger core to advice on treating cataracts. PLUS, the latest news on medical advances and breakthroughs from Harvard Medical School experts.

New Blood Test May Predict Alzheimers Disease

A new blood testing technique could help researchers detect Alzheimers disease before symptoms start or in its early stages.

Alzheimers disease is an age-related brain disorder that develops over many years. Toxic changes in the brain slowly destroy memory and thinking skills.

The disease involves two proteins called beta-amyloid and tau. Beta-amyloid clumps into plaques, which slowly build up between brain cells. Abnormal tau collects inside brain cells and forms tangles.

Researchers investigated whether a new blood testing technique could help predict development of Alzheimers disease. They tested for a modified version of tau called ptau181 in blood plasma . Levels of this protein have been linked with Alzheimers disease.

The team collected blood samples from more than 400 people. The analysis showed that ptau181 levels differed between healthy participants and those with Alzheimers disease.

The new approach could be less invasive and costly than current tests for Alzheimers disease. These rely on brain scans and lab tests of spinal fluid.

The development of a blood test would enable us to rapidly screen a much larger and more diverse group of volunteers who wish to enroll in studies, says Dr. Richard J. Hodes, director of NIHs National Institute on Aging.

Don’t Miss: How To Talk To Dementia Patients

RELATED ARTICLES

Most Popular